News and Comments

Biotechnology Companies: A Model that’s Gaining Visibility

  Tuesday, December 07, 2010

The biotechnology company model founded on management skills rather than purely on scientific skills has begun to gain investors’ appreciation. The reason is that many firms built around skilled, experienced entrepreneurs have succeeded in bringing a large number of drugs to the market and in marketing them competently. These firms license or acquire drugs in mid-or late-phase trials. They sometimes acquire therapeutic molecules in early-stage development only if these molecules prove to have optimal affinity on validated proteins in pathways of diseases, and produce desired agonist or antagonist effects. In order to select the products that can be called breakthroughs, the most successful of the firms established and run by entrepreneurs with strong business acumen employ specialists in pharmaceutical sciences and in clinical trials. These scientists have experience in sensitive areas such as drug development, clinical trials, medicinal chemistry, and other important disciplines required for drug discovery, development and testing.   More...


Recent Postings


Archive


Tags

KERYX (KERX) Dendreon (DNDN) TOKAI (TKAOI) Abbott Laboratories (ABT) Intermune (ITMN) Idenix (IDIX) Seattle Genetics (SGEN) REGULUS (RGLS) ABBVIE (ABBV) Anacor (ANAC) Alder Biopharmaceuticals (ALDR) RenenxBio (RGNX) Exelixis (EXEL) Agenus (AGEN) Genentech Sequenom (SQNM) SUNESIS PHARMACEUTICALS (SNSS) AERIE PHARMACEUTICALS ZALTRAP™ KITE (KITE) Global Cell Therapeutics (GBT) Roche (RHHBY) Cytokinetics (CYTK) Roche (ROCHE) PTC Therapeutics (PTCT) GUARDIAN HEALTH Human Longevity (HLI) Endometrial Cancer Revlimid (lenolidamide) Tysabri Rapamune C4 Therapeutics Vertex (VRTX) Elan (ELN) HALOZYME (HALO) Theravance (THRX) Auspex (ASPX) Ridaforolimus Array Pharmaceuticals (ARRY) BIOMARIN (BMRN) Zerenex Sanofi (SNY) Trastuzumab-DM1 Sanofi (SNA) Intrexon (XON) Human Genome Sciences (HGSI) ARGOS (ARGS) Intercept (ICPT) Onyx (ONXX) Anadys (ANDS) Bristol-Myers Squibb (BMY) Regeneron (REGN) GlaxoSmithKline (GSK) Spike Therapeutics (ONCE) galapagos (GLPG) Telaprevir Biocryst (BCRX) Micromet (MITI) Sarepta (SRPT) ImmunoGen (IMGN) JUNO (JUNO) ADVENTRIX (ANX) Ziofpharm (ZIOP) Dynavax (DVAX) Prolor Biotech (PBTH) OSI (OSIP) Sanofi-Aventis (SAN) Valeant Pharmaceuticals International (VRX) NANTKWEST (NK) CompuGen (CGEN) Velcade (bortezomib) Aimmune Therapeutics (AIMT) Vitae Pharmaceuticals (VTAE) Agenus (AGEN Gilead (GILD) Benlysta (belimumab) Ionis (IONS) Inovio (INO) Pluristem (PSTI) Merck (MRK) Jazz Pharmaceuticals (JAZZ) AGOS (ARGS) NEKTAR (NKTR)) INNOVIVA (INVA) Mirati Therapeutics (MRTX) Sangamo (SGMO) Illumina (ILMN) Herceptin SYNTA (SNTA) Alnylam (ALNY) ARCA (ABIO) Editas (EDIT) Ariad (ARIA) SERES THERAPEUTICS (MCRB) Prosensa (RNA) Multiple Myeloma ISIS (ISIS) Galena (GALE) Theravance Bio Pharma (TBPH) Amgen (AMGN) IDERA (IDRA) Biogen Idec (BIIB) VANDA (VNDA) ACADIA (ACAD) Xoma (XOMA) Incyte (INCY)